Search results
Mar 25, 2024 · Paxlovid, an oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it within the first five days of experiencing symptoms, it will lower your risk of getting so sick that you need to be hospitalized.
Jan 11, 2024 · As hospitalizations and deaths from Covid-19 rise, fueled by a fast-moving new variant that now accounts for a majority of U.S. cases, Paxlovid can help protect patients from some of the worst...
Jun 7, 2024 · A five-day Paxlovid regimen has been shown to reduce recipients’ likelihood of hospitalization and death by more than 85%. While the Stanford trial did not show that Paxlovid reduced long COVID symptoms, it did show that taking the drug for more than two weeks was safe.
The US Food and Drug Administration (FDA) approved Paxlovid last May for the treatment of mild to moderate COVID-19 in adults who are at risk of progression to severe disease.
Jan 25, 2024 · Paxlovid is extremely effective when taken within five days of symptom onset. In clinical trials, it reduced the risk of hospitalization and death by almost 90% in unvaccinated people. “It’s a tremendous tool that's completely underutilized,” says Adalja.
• Paxlovid (ritonavir-boosted nirmatrelvir) is a preferred oral antiviral authorized for the treatment of mild-moderate COVID-19 illness. • Patients take a combination of pills twice a day for 5 days.
May 13, 2022 · Paxlovid has been found to be about 88% effective in preventing hospitalization and death in unvaccinated, high-risk adults with COVID-19.
